Andrew P. Beame
Counsel
212-336-2704 |
212-336-7916 fax |
Download V-Card
Andrew P. Beame's practice focuses on corporate transactional matters, primarily focusing on private equity, venture capital financing and mergers and acquisitions. Mr. Beame represents a wide variety of clients ranging from emerging growth and public companies to private equity investment firms. Mr. Beame’s recent transactions include presenting a spirits company in its initial public offering, representing private equity firms in acquisitions in the cosmetics, food products and biotechnology industries, representing a large multinational corporation with a strategic investment in a private company and representing both venture-backed companies and venture capital firms in equity financing transactions. Mr. Beame regularly advises emerging growth companies in all stages of their life cycle in areas such as entity formation, contracts, employee compensation, capital raising and mergers and acquisitions. He has served as counsel for companies in a broad range of industries, including life sciences, software, biopesticide, reinsurance, spirits, financial services and education.
Representative Matters
Venture Capital and Private Equity Transactions
Represented private equity firm in connection with the acquisition of a high-end cosmetics company.
Represented private equity firm in venture capital and private equity transactions including investments in various emerging growth companies and the sale of a company purchased in a previous investment.
Represented global media and entertainment company in connection with a strategic equity investment in a private company.
Represented private equity firm in connection with an investment in a biotechnology venture.
Represented financial information software company in negotiation and consummation of equity and bridge loan financing transactions with venture capital and private investors.
Represented major pharmaceutical company in a series of strategic investments in private companies and in a transaction involving the disposition of assets in connection with the settlement of a litigation.
General corporate representation of a private reinsurance company including representation in connection with several venture capital financing transactions.
Assisted start-up corporations and limited liability companies in the Internet, biotechnology, biopesticide, education and insurance industries in connection with early stage financings, strategic transactions, contract negotiations and general corporate advice.
Mergers and AcquisitionsRepresented education company in a merger transaction whereby the company was sold to a major publishing and information services company.
Represented major international media company in connection with its third party tender offer for a public company that designs and markets casual and athletic footwear and apparel and the ensuing going private transaction.
Represented major magazine publishing company in the acquisition of an e-commerce magazine and in a series of other acquisitions of magazine-related assets.
Consummated merger of two private financial services companies.
Consummated merger of two public companies, including acquisition of private company prior to the public merger.
Securities Transactions and General Corporate
Represented premium spirits company in their initial public offering and in their convertible debt financing and retail private placement prior to the initial public offering.
Represented financial institution in cross-border debt and equity transactions relating to American Depository Receipts.
Represented public biotechnology company in connection with a convertible debt PIPE transaction.